The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALPHABET INC | CAP STK CL C | 02079K107 | 15,226 | 100 | SH | SOLE | 100 | 0 | 0 | ||
ARDELYX INC | COM | 039697107 | 7,640,669 | 1,046,667 | SH | SOLE | 1,046,667 | 0 | 0 | ||
AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 1,393,425 | 82,500 | SH | SOLE | 82,500 | 0 | 0 | ||
BATTALION OIL CORPORATION | COM | 07134L107 | 112,781 | 19,926 | SH | SOLE | 19,926 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 1,085,768 | 848,256 | SH | SOLE | 848,256 | 0 | 0 | ||
BURGERFI INTERNATIONAL INC | COM | 12122L101 | 1,585,779 | 2,745,938 | SH | SOLE | 2,745,938 | 0 | 0 | ||
BURGERFI INTERNATIONAL INC | *W EXP 12/16/202 | 12122L119 | 81,254 | 2,083,438 | SH | SOLE | 2,083,438 | 0 | 0 | ||
ENPHYS ACQUISITION CORP | CL A ORD SHS | G3167L109 | 845,313 | 78,125 | SH | SOLE | 78,125 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 1,890,400 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 1,980,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
HUMACYTE INC | COM | 44486Q103 | 730,850 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 1,908,189 | 70,335 | SH | SOLE | 70,335 | 0 | 0 | ||
ISHARES TR | RUSSELL 2000 ETF | 464287655 | 52,049,250 | 247,500 | SH | Put | SOLE | 247,500 | 0 | 0 | |
JASPER THERAPEUTICS INC | COM NEW | 471871202 | 939,520 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 2,578,533 | 130,691 | SH | SOLE | 130,691 | 0 | 0 | ||
LUMOS PHARMA INC | COM | 55028X109 | 256,039 | 90,794 | SH | SOLE | 90,794 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 19,156,989 | 2,119,136 | SH | SOLE | 2,119,136 | 0 | 0 | ||
MICROSOFT CORP | COM | 594918104 | 42,072 | 100 | SH | SOLE | 100 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 4,117,371 | 2,300,207 | SH | SOLE | 2,300,207 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 774,600 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,130,400 | 45,000 | SH | Put | SOLE | 45,000 | 0 | 0 | |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 1,034,400 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 684,775 | 32,500 | SH | SOLE | 32,500 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 347,225 | 42,500 | SH | SOLE | 42,500 | 0 | 0 | ||
SEMTECH CORP | COM | 816850101 | 385 | 14 | SH | SOLE | 14 | 0 | 0 | ||
SEMTECH CORP | COM | 816850101 | 68,725,000 | 2,500,000 | SH | Call | SOLE | 2,500,000 | 0 | 0 | |
SERES THERAPEUTICS INC | COM | 81750R102 | 263,783 | 340,761 | SH | SOLE | 340,761 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 4,744,500 | 50,000 | SH | Put | SOLE | 50,000 | 0 | 0 | |
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 58,943 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,547,000 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 601,380 | 78,000 | SH | SOLE | 78,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 629,500 | 1,000,000 | PRN | SOLE | 1,000,000 | 0 | 0 |